Additional European Equity News
GSK (GSK LN) - FDA to review Gonorrhea indication for Gepotidacin; US decision exp. in Dec 2025. (Newswires)
Plus 500 (PLUS LN) - Announced USD 165mln in shareholder returns. FY25 results are exp. to be in-line with current market expectations. (Newswires)
Serco (SRP LN) - Announced up to GBP 50mln share buyback programme. (Newswires)
S4 Capital (SFOR LN) - Co. confirms a proposal from MSQ Partners for combination - highlights discussions are at a prelim stage. (Newswires)
11 Aug 2025 - 07:04- ForexEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts